International Journal of
Reproductive Biomedicine
Wed, May 14, 2025
[Archive]
Volume 19, Issue 5 (Suppl- 2021)
IJRM 2021, 19(5): 172-172 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Naseri L, Khazaei MR, Khazaei M. P-5 Potential therapeutic effect of bee pollen and metformin combination on testosterone and estradiol levels, apoptotic markers and total antioxidant capacity in a rat model of polycystic ovary syndrome. IJRM 2021; 19 (5) :172-172
URL: http://ijrm.ir/article-1-2862-en.html
URL: http://ijrm.ir/article-1-2862-en.html
1- Student Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran
2- Fertility and Infertility Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.
3- Fertility and Infertility Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran. ,mkhazaei1345@yahoo.com
2- Fertility and Infertility Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.
3- Fertility and Infertility Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran. ,
Abstract: (283 Views)
Background: Polycystic ovary syndrome (PCOS) is associated with metabolic disorders as well as infertility. Many traditional remedies have been reported to show estrogenic and antioxidant potential. Bee pollen (BP) is a natural compound, reported as one such remedy.
Objective: The present study aimed to investigate the effects of BP extract (BP) and metformin (MET) on estradiol (E2) and testosterone (T) levels, apoptotic markers, and total antioxidant capacity (TAC) in a rat model of PCOS.
Materials and Methods: In this experimental study, 54 female Wistar (n = 6/group) rats received 2 mg of estradiol valerate (EV) intramuscularly and 6 additional rats were considered the control without EV injection. The rats were treated with BP (50, 100, and 200 mg/kg), MET (300 mg/kg) and BP+MET (50 BP+300 MET, 100 BP+300 MET, and 200 BP+300 MET mg/kg). Serum levels of E2 and T were assessed by the ELISA method. TAC of serum was also determined. The expressions of Bcl2, Bax, Caspase3 (Cas-3), and Sirt-1 genes were evaluated by real-time polymerase chain reaction (PCR). Data were statistically analyzed using one-way ANOVA.
Results: In the untreated PCOS group E2 and T levels (p < 0.01), and Bcl2 (p = 0.007) expression were increased, but TAC (p = 0.002) and expression of Bax (p = 0.001), Cas-3 and Sirt-1 (p < 0.01) were decreased significantly. The levels of E2 and T, as well as the expressions of Bcl2, were decreased in all treated groups compared to the untreated PCOS group (p < 0.01). On the other hand, TAC and expression of Bax, Cas-3and Sirt-1 were increased in the BP- and MET-treated groups (p < 0.05).
Conclusion: BP and MET synergistically improved serum E2, T, and TAC levels, and expression of apoptotic genes.
Objective: The present study aimed to investigate the effects of BP extract (BP) and metformin (MET) on estradiol (E2) and testosterone (T) levels, apoptotic markers, and total antioxidant capacity (TAC) in a rat model of PCOS.
Materials and Methods: In this experimental study, 54 female Wistar (n = 6/group) rats received 2 mg of estradiol valerate (EV) intramuscularly and 6 additional rats were considered the control without EV injection. The rats were treated with BP (50, 100, and 200 mg/kg), MET (300 mg/kg) and BP+MET (50 BP+300 MET, 100 BP+300 MET, and 200 BP+300 MET mg/kg). Serum levels of E2 and T were assessed by the ELISA method. TAC of serum was also determined. The expressions of Bcl2, Bax, Caspase3 (Cas-3), and Sirt-1 genes were evaluated by real-time polymerase chain reaction (PCR). Data were statistically analyzed using one-way ANOVA.
Results: In the untreated PCOS group E2 and T levels (p < 0.01), and Bcl2 (p = 0.007) expression were increased, but TAC (p = 0.002) and expression of Bax (p = 0.001), Cas-3 and Sirt-1 (p < 0.01) were decreased significantly. The levels of E2 and T, as well as the expressions of Bcl2, were decreased in all treated groups compared to the untreated PCOS group (p < 0.01). On the other hand, TAC and expression of Bax, Cas-3and Sirt-1 were increased in the BP- and MET-treated groups (p < 0.05).
Conclusion: BP and MET synergistically improved serum E2, T, and TAC levels, and expression of apoptotic genes.
Type of Study: Congress Abstract |
Subject:
Pregnancy Health
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
